Article
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
BJU international - 1 Oct 2012
van Rhijn Bas W G, Liu Liyang, Vis André N, Bostrom Peter J, Zuiverloon Tahlita C M, Fleshner Neil E, van der Aa Madelon N M, Alkhateeb Sultan S, Bangma Chris H, Jewett Michael A S, Zwarthoff Ellen C, Bapat Bharati, van der Kwast Theo H, Zlotta Alexandre R
Abstract excerpt
UNLABELLED: What's known on the subject? and What does the study add? The stakes are high when making treatment decisions in T1 bladder cancer (BC). Conservative management may lead to progression and possibly death from BC. Conversely, radical cystectomy could be over-treatment of non-progressive disease. The problem for clinicians is that reliable prognostic indices are lacking. We performed a head-to-head...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.